ѧѧ
ACTASCIENTIAECIRCUMSTANTIAE
19985µ185ڿƼڿ
Ѫ쵰-ϩӺķ*

(ȻѧίԱᣬ100083)

(йѧԺ̬оģ100085)
Rappaport S. M.
(UNC AT CHAPEL HILL, USA)
ժҪûϩ(SO)Ѫ쵰ϻλļӺͬʱⶨķԴ(SD)Ѫ쵰-SOӺʵ鼰ǻע价ϩͱϩʵ.Ѫ쵰3ּӺ(SG1-PE2-PE)SOӣװӺӺ֮Ÿͬʵͬ2-PE1-PEʽΪ㶨˵SOͰװᷴӦλڦλͼŨǣSGΪ8 pmol/g()1-PEΪ5pmol/g()2-PEΪ0.6 pmol/g().
ؼʡʼӺѪ쵰ףϩϩ.
ANALYSIS OF STYRENE OXIDE-HEMOGLOBIN ADDUCT

Jin Zuliang
(National Natural Science Foundation of China, Beijing 100083)
Liu Shufen
(Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085)
Rappaport S. M.
(UNC at Chapel Hill, Chapel Hill, NC 27599-7400,USA)

ABSTRACTAn assay is described for measures of adducts of styrene oxide (SO) with hemoglobin(Hb) wich have been modified at residues containing either carboxylic acid or sulfhydryl groups. In the first, SO-carboxylic acid adducts are hydrolyzed in basic medium to liberate styrene glycol(SG). Then, the remaining residues are reacted with a reductive catalyst (Raney nickel) to liberate the two positional isomers of SO-cysteine adducts, i.e., -phenylethanol(2-PE) and -phenylethanol(1-PE). The products are derivatized with pentafluorobenzoyl chloride and measured by GC-NICI-MS.
The assay was evaluated with SO adducts of Hb which had been produced in the blood of S-D rats following (a) in vitro modification or (b) i.p. administration of either SO or styrene. Levels of the three analytes (SG,1-PE and 2-PE) increased with dose in hemoglobin. Binding of SO to cysteine residues of blood proteins is greatly preferred at the -position rather than the -position both in vitro and in vivo. The lowest detectable adduct concentrations are 8 pmol/g protein for SG, 5 pmol/g protein for 1-PE, and 0.6 pmol/g protein for 2-PE.
Keywordsstyrene oxide-hemoglobin, adduct.
ϩϺ𽺹ҵҪĵ֮һ1ݣͬʱҲ㷺ڻУβˮʳƷװжз.ϩְҵӴҪͨƤգһȺĵŨȽӴҪϰװʳƷ.ϩҪлǻϩ(SO)2ݣʵָϩͻ»°ã3.оֻϩDNA͵ʵ׺˲γɹDNA-Ӻ4ݺ͵ʼӺ5.
κ׺˵İĩ˶SOӺܷƣĿǰԼְϣѪ쵰(Hb)N-ĩӰ4ݡװ6ݡĩˣ7ݣԭЩʼӺ׷.оͬһHbƷͬʱⶨSO-ӺSO-װӺ(3ּӺ)ķԼ򵥣ȸߣ٣㷺ڵʼӺΪ־о.
1
1.1ѧƷ
ϩ(99%)ϩ(99%)RaneyN嶡ǰ(NBS)4-׻ϩ2-PE4-׻Ҵ(4-m2-PE)(ˮ)(PFB-)ȹAldrich˾SO(97%)Fluka Chim˾øSephadex G-25 (2080m)Sigma˾ѹMallinkrodt˾ˮƹJ.T. Baker˾(ũҩ)Fishev˾ˮMillin-Qϵͳ.
1.2ֻѧƷĺϳ봿
4-׻Ҷ(4mSG)ĺϳɺʹĹ£0.45mol 4m-SO100mL0.1mol HCl10minˮ20mLȡΣN2µİɫΪ4m-SGո󣬲õӺ(EI-MS)ϸ̲οף6.ͬķϳɺͼ4m-SO-Hb.
1.3
ӻѧԴɫGC/MS-(NICI)(HP-5989A)Ļ-ɼֹǣո䣬ˮԡ.
2ʵ鷽
2.1ƷƱ
(a)ⷴӦƷƱ0.5mLSOˮҺ(07.5mmol/L)뵽1.2mLʵĴȫѪУʹյҺSOŨΪ01030100300mol/LƷˮԡУ372hԵҡ.(b)ʵƷƱ͵ıϩSOע䵽SDǻڣֱΪϩ00.51.03.0mmol/kg()SOΪ00.10.31.0mmol/kg()ע24hüøشעӴȡѪ.(c)Ѫ쵰׷봿ȫѪƷ100gĻ20minѪͺѪ(Ѫ䶳)ˮϴѪȻõȥˮƻѪ521000g40minȥϸϸڣٽҺͨSephadex G-25͸ȥСĵʣHbҺԱͪУķ򵰰׹壬ϴӣ40ոﵽ.
2.2Ʒˮ
20mg򵰰Ʒ(Gb)10g4-m-SO-ʱ4mLˮУӵƷҺ7ĸø37ø4hϵĽ裬Ȼ1mL NaOH(1mol/L)øƷ5minȴ25mLȡ.
2.3Raneyn߻ԭ
ºʵˮҺ0.2mol/L HClpH=7ÿƷм6GbRaney1ngɱ3-PP4ҡ40minȻ5mLȡ.
2.4Ʒ
ȡҺڵŨ3mL350mgˮNa2SO4ȡȻƷתƵСԼƿУһŨɹ̣1mLܽ⣬3Lण1.5L PFB-ȣ50·Ӧ20min.Ӧȴ0.5mL85%״ˮҺϴӣGC/MS.
2.5GC/MS
ƷøӻѧԴGC/MSʯӢëϸ(30mھ0.242mm)1mmȵDB-5۹ĳ¶ȿƶSG-PFB4- m-SG-PFBΪ75汣1min50/minٶ250棬20min1-PE-PFB2-PE-PFB4-m-2-PE-PFB3PP-PFBΪ75汣1min50/minٶ200,8min50/minٶ250棬11minӻԴ¶150棬Ƿ¶250棬NICIķӦΪ(2133.3Pa)ΪHe(Psi)M/Z 316(SG-PFB1-PE-PFB2-PE-PFB)M/Z 333(4m-SG-PFB4m-2-PE-FB3-PP-PFB)ѡԵӼ⣬ݷıʱΪSG-PFB=12.7min4m-SG-PFB=14.7min1-PE-PFB=9.5min2-PE-PFB=10.9min4M-2-PE-PFB=12.9min3-PP-PFB=13.5min.ĳЩƷHP5971Aѡз(MSD)ͬëϸ(DB-5)¶ȳMSDĽ¶280棬70eVԴ£50650uΧɨEI.
3
ͼ1ͼ2300mol SOѪⷴӦ̷Ʒøʹ߻ԭM/Z50-550ΧɨGC/MSɫͼƷͬʱɫ׷EIͼ.ͼ1ɿˮΪҶȵ(SG-PFB)ԣͼ2Raney߻ѽΪ1-PE2-PEǵ(1-PE-PFB2-PE-FB)ԣͬһƷУòͬĹ̿Բ3ֲͬļӺ.
1(LOD)ƷͼŨ(LDSC)*
Table 1 The limit of determination (LOD) andthe lowest detectable concentration(LDSC)

ƷpgLOD,fmolLDSC,pmol/g
SG100.658.13
4M-SG101.39
1-PE10.405.30
2-PE10.050.61
4M-PE10.10
3-PP10.13

* 10mgƷ0.1mL1L


ͼ1SOⷴӦӺͼ(ˮ)
A: B15.45minɨ C:
Fig.1 GC/MS/EI analysis of SO-protein adduct in vitro 


ͼ2SOⷴӦӺͼ(߻Ӧ)
A: B12min CE: D14.44min
Fig.2 GC/MS/EI analysis of SO-protein adduct(Rainy neckel)in vitro
Ϊ߷ȣӦ˸ӻѧԴGC/MSѡԵĶӼƷSG-PFB1-PE-PFB2-PE-FBԼ4m-SG-PFB4m-PE-PFB3-PP-PFBļ110mgƷյҺ0.1mLտɼӺŨΪSGΪ8pmol/g()1-PEΪ5pmol/g()2-PEΪ0.6pmol/g().Էľܶʵǲ0.5mgڱ4m-SO-Gb30η(ƷƷHb)ϵΪ12%.ԵʼӺȶԵʵ飬-80ƷеĵʼӺŨһûԵı仯.
ôȫѪSOⷴӦƷͼ3ʾ⵰ʼӺSOĹϵSO-YʼӺŨȣYHbеİװᣬSO-YĵλΪmol/L.ͼ3ؿSOѪⷴӦγɵļӺнϺõ.
ͼ4ͼ5ʾñϩSOֱעĸǻڷӦѪγɵʼӺӦϵ.ͼ45ԵĿԿñôѪе3ֲͬSO-ʼӺнϺõ.


ͼ3SOѪⷴӦӺĹϵ
A:Hb-SG B:Hb-1-PE and 2-PE
Fig.3 Modification of rat blood by SO in vitro



ͼ4SOڴڷӦӺĹϵ
A:Hb-SG B:Hb-1-PE and 2-PEFig.4 Modification of rat blood by SO in vivo


ͼ5ϩڴڷӦӺĹϵ
A:Hb-SG B:Hb-1-PE and 2-PEFig.5 Modification of rat blood by styrene in vivo
2гSOѪⷴӦγɼӺ칹ıʣɱ2Կ⻹ڷӦװļӺᣬSOеĦλڦλ.
2SOͬ칹Ӻγɱ
Table 2 The ratio of protein adducts in different binding sitesaction

ӺSO()SO() ϩ()
SO-ⰱ/SO-651544
SOⰱ/SOⰱ6.65.36.2


4
ͬһƷͬʱⶨͬӺϵ°뵰ʼӺΪӴ°ⷽޱӺˮƽ൱ַõĲͬӺϵӺŨӣ߷ȣͬʱԱȽϲͬӺϵļӺŨ.һԣͬļӺвͬЧӦӶѡʵļӺΪ־.ˮķ°ӺGanоģ8.Day9ݺSepai10ݽڲSO-ʼӺͼƷŨ15pmol/g().ǵоøԼʹƷȫˮ⣬ͼŨΪ8pmol/g().
ɱ2ԿSO벻ͬİĩγɼӺͬSOװγɼӺSOļӺ.SOҲѪ쵰춬ᡢȰĩγSO-ӺǼӺŨȵͣҲڵʴͳĹˮ,ײⶨ.ԸݱʵĽԱȸӺγƷͼŨȣһѡSO-װӺΪӴSO־.
Pachecka SO׸ķӦγɼӺıǦλ/λ=60/4011ݣYagen SON-װᷴӦּӺıǦλ/λ=65/3512ݣHemmikiSOװᷴӦ칹ıǦλ/λ=2/15(뱾ʵ鷽ͬ)ʵǦλ/λ=6.65.46.2,ܽӽ(ͬķӦ)˵òͬİĩ˷ӦԲͬļӺ칹ʣԭдһоݱʵһѡλӺΪоӴSOߴ.
Ȼѧ(ţ5954300629577289)ְҵ뽡
ο
1Bond J A. Review of the toxicology of styvene. Crit Rev Toxicol, 1989, 19:227249
2Leibman K C, Ortiz E. Oxidation of styrene in liver microsomes. Biochem Pharmacol, 1969,18:552554
3Ponomarkov V, Cabral JR P, Wahrendorf J et al. A carcinogenicity study of styrene-7,8 oxide in rats. Cancer Lett, 1984, 24:95101
4Nordqvist B M,Lof A, Osterman-Golkar S et al. Covalent binding of styrene and styrene 7,8-oxide to plasma proteins, hemoglobin and DNA in the mouse. Chem Biol Interact, 1985,55:6373
5Hemminki K. Binding of styrene oxide to amino acids, human serum proteins and hemoglobin. Arch Toxicol. Suppl, 1986,9:286290
6Rappaport S M, Ting D,Jin Z et al. Application of Raney nickel to measure adducts of styrene oxide with hemoglobin and albumin. Chem Res Toxicol, 1993,6:238244
7Day B W, Naylor S Gan, Sahali L S et al. Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts. Cancer Res, 1990,50:46114618
8Gan L S,Wishnok J S, Fox J G. Quantitation of methylated hemoglobin via hydrolysis of methyl esters to yield methanol. Anal Biochem, 1989,179:326331
9Day B W,Naylor S Gan, Sahali L S et al. Gas chromatographic-mass spectrometric analysis of diols and tetrols from reactions of polycyclic aromatic hydrocarbon epoxides with hemoglobin. J Chromatogr, 1991,562:563571
10Sepai O, Anderson D, Street B et al. Monitoring of exposure to styrene oxide by GC/MS analysis of phenylhydroxyethyl esters in hemoglobin. Arch Toxicol, 1993,67:2833
11Pachecka J, Gariboldi P,Cantoni et al. Isolation and structure determination of enzymatically formed styrene oxide glutathione conjugates. Chem Biol Interact, 1979,27:313321
12Yagen B,Hermandez O,Bend J R et al. Synthesis and relative stereochemistry of the four mercapturic acids derived from styrene oxide and N-acetylcysteine. Chem Biol Interact, 1981, 34:5767
